STUDY: People Who Received Ivermectin Were Better Off
(The Epoch Times) People who tested positive for COVID-19 and took ivermectin as a treatment recovered faster than a comparison group, a new study found.
The time to self-reported recovery was a median of two days faster among the ivermectin recipients, according to the large UK study.
The quicker recovery period was statistically significant.
People who received ivermectin were also less likely to be hospitalized or die, with 1.6 percent of ivermectin recipients being hospitalized or dying versus 4 percent of the comparison group, which received typical care, which in the UK is largely focused on managing symptoms.
Ivermectin recipients also enjoyed a reduction of severe symptoms and sustained recovery, according to the study.
The paper was published by the Journal of Infection on Feb. 29.
The study covered an open-label trial that involved 2,157 ivermectin recipients and 3,256 who received typical care from June 23, 2021, to July 1, 2022. Participants were randomized and reported symptoms and recovery.
The researchers then claim that the findings don’t support using ivermectin:
The authors, including Christopher Butler, a University of Oxford professor and joint chief investigator of the trial, downplayed the positive findings in part because the hazard ratio of 1.14 was lower than what authors pre-specified as a meaningful ratio, or 1.2. Hazard ratios are a way to determine whether a treatment is beneficial.
The authors also focused on the lack of differences in the number of days participants felt sick in the previous two weeks, impact on work, and likelihood of using the health care system at 3, 6, and 12 months following treatment.
“Overall, these findings, while evidencing a small benefit in symptom duration, do not support the use of ivermectin as treatment for COVID-19 in the community among a largely vaccinated population at the dose and duration we used,” the authors said.
